CTOs on the Move

Dispersol Technologies

www.dispersoltech.com

 
DisperSol Technologies provides expertise in formulation and processing technologies for solubility/bioavailability enhancement of poorly water-soluble drug molecules.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Chris Brough
Chief Technology Officer Profile

Funding

Dispersol Technologies raised $27M on 04/26/2018

Similar Companies

Design Clinicals

Design Clinicals is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Tukwila, WA. To find more information about Design Clinicals, please visit www.designclinicals.com

Greater Columbia Behavioral Health

Greater Columbia Behavioral Health is a Kennewick, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Go-Girl

Go-Girl is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AMN Healthcare

AMN Healthcare is the innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. AMN Healthcare`s workforce solutions - including managed services programs and recruitment process outsourcing - enable providers to successfully reduce complexity, increase efficiency and improve patient outcomes within the rapidly evolving healthcare environment. The Company provides unparalleled access to the largest network of quality clinicians and physicians through its innovative recruitment strategies and breadth of career opportunities. Clients include acute-care hospitals, government facilities, community health centers and clinics, physician practice groups and many other healthcare settings.

Nymox

NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.